Isolated pelvic perfusion: plasma pharmacokinetics depend primarily on drug dosage and not the type of drug-Reference-Cited by-同舟云学术

Isolated pelvic perfusion: plasma pharmacokinetics depend primarily on drug dosage and not the type of drug

Published:2005-01-15 Issue:4 Volume:55 Page:318-322
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Belliveau James F.,Arevalo Elisabeth,Griffin Hank,Wanebo Harold J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-004-0895-x.pdf

Reference10 articles.

1. Belliveau J, Wanebo H (2003) Clinical experiences and pharmacology with isolated pelvic perfusion (IPP) for lower GI cancers. Proceedings of the 14th International Congress on Anti-Cancer Treatment, Paris (P059) 14:206

2. Creech O, Krementz ET, Ryan RF, Winblad JN (1958) Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148:616

3. Darnowski JW, Sawyer RC, Stolfi RL, Martin DS, Lau-Cam CA (1985) Decreased host toxicity in vivo during chronic treatment with 5-fluorouracil. Cancer Chemother Pharmacol 14:63

4. Forastiere AA, Belliveau JF, Goren M, Vogel WC, Posner MC, O?Leary GP (1988) Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloro-platinum (II) in head and neck cancer patients. Cancer Res 48:3869

5. den Hartigh J, van Oort WJ (1981) High-pressure liquid chromatographic determination of the antitumor agent mitomycin C in human blood plasma. Anal Chim Acta 127:47

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimizing Systemic Leakage of Cisplatin during Percutaneous Isolated Pancreas Perfusion Chemotherapy: A Pilot Study;Radiology;2015-07

2. Feasibility and Safety of Negative-Balance Isolated Pelvic Perfusion in Patients with Pretreated Recurrent or Persistent Uterine Cervical Cancer;Annals of Surgical Oncology;2015-03-11

3. Negative-balance isolated pelvic perfusion in patients with incurable symptomatic rectal cancer: results and drug dose correlation to adverse events;Acta Radiologica;2014-09

4. Pharmacologic Advantages of Negative-Balance Isolated Pelvic Perfusion: Achievement of Intensive Exposure of the Pelvis to Platinum without Systemic Leakage;Radiology;2012-02

5. Hyperthermic Pelvic Perfusion With Tumor Necrosis Factor-α for Locally Advanced Cancers;Annals of Surgery;2012-02